Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. ResApp Health Limited
  6. News
  7. Most relevant
    RAP   AU000000RAP5

RESAPP HEALTH LIMITED

(RAP)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about RESAPP HEALTH LIMITED
06/03RESAPP HEALTHá : Medgate extends European ResAppDx trial
PU
05/17RESAPP HEALTHá : Recruits First Participant in COVID-19 Study; Shares Jump 6%
MT
05/04RESAPP HEALTHá : Signs Distribution Deal for Smartphone Diagnostic App in Kenya;..
MT
05/03RESAPP HEALTHá : Agreement secured with Ilara Health to sell ResAppDx in Kenya
PU
04/12RESAPP HEALTHá : Raises Over $4 Million in Placement
MT
04/11RESAPP HEALTHá : secures firm commitments to raise $5.5 million
PU
03/24RESAPP HEALTHá : Secures Regulatory Clearance in Australia for Wearable Medical ..
MT
03/24RESAPP HEALTHá : TGA clearance achieved for wearable
PU
03/11RESAPP HEALTHá : Grants AstraZeneca License for Cough Counting Tech for Asthma P..
MT
03/10RESAPP HEALTHá : to Conduct Study to Develop Smartphone-Based COVID-19 Screening..
MT
03/04RESAPP HEALTHá : Partner Begins Trial of ResAppDx in Switzerland
MT
03/01RESAPP HEALTHá : Secures CE Mark Certification for Wearable Device
MT
02/24RESAPP HEALTHá : Morgans rates RAP as Add
AQ
02/04RESAPP HEALTHá : Receives R&D Tax Incentive Refund, Export Grant
MT
02/02RESAPP HEALTHá : Receives European Patent for Cough Detection Technology; Shares..
MT
2020Australian Shares Rise on Signing of US Pandemic Relief Bill; Queensland Reco..
MT
2020RESAPP HEALTHá : Launches SleepCheck App on Some Android Devices; Shares Gain 8%
MT
2020RESAPP HEALTHá : Cancels Partnership With RB; Shares Down 4%
MT
2020RESAPP HEALTHá : Advances Development of ResAppDx Application
MT
2020RESAPP HEALTHá : Expects US FDA Meeting to Make Way for Clearance of SleepCheck
MT
2020RESAPP HEALTHá : Respiratory Diagnosis Software to Integrate into a Holistic Tel..
MT
2020RESAPP HEALTHá : Partners With Medgate to Pilot ResAppDx for Telehealth Services..
MT
2020RESAPP HEALTHá : Morgans rates RAP as Add
AQ
2019RESAPP HEALTHá : 2019 Letter to Shareholders
PU
2017RESAPP HEALTHá : Updated Corporate Governance Policies
PU
2017RESAPP HEALTH (ASX : RAP) talks study results and clinical trials
FI
2017RESAPP HEALTHá : Update on Field Evaluation by Médecins Sans Frontières/Doctors ..
PU
2017RESAPP HEALTHá : Update on Field Evaluation by Medecins Sans Frontieres
PU
2017RESAPP HEALTHá : SMARTCOUGH-C Study and Paediatric Clinical Strategy Update
PU
2017RESAPP HEALTHá : Appendix 4E - Preliminary Final Report
PU
2017RESAPP HEALTHá : Dr Philip Currie Joins ResApp's Scientific Advisory Board
PU
2017RESAPP HEALTHá : Dr Philip Currie Joins ResApp's Scientific Advisory Board
PU
2017RESAPP HEALTHá : Receives R&D Tax Incentive Cash Refund for FY16
PU
2017RESAPP HEALTHá : Reports Preliminary Top-line Results from SMARTCOUGH-C Study fo..
PU
2017RESAPP HEALTHá : Change of Director's Interest Notice
PU
2017RESAPP HEALTHá : Investor Conference Call
PU
2017RESAPP HEALTHá : Appendix 4C - Quarterly Jun 2017
PU
2017RESAPP HEALTHá : Investor Presentation
PU
2017RESAPP HEALTHá : Morgans Initiates Research Coverage
PU
2017RESAPP HEALTHá : Release of Restricted Securities
PU
2017RESAPP HEALTHá : Announces Completion of Enrolment in SMARTCOUGH-C Study
PU
2017RESAPP HEALTHá : Completion of Enrolment in SMARTCOUGH-C Study
PU
2017RESAPP HEALTHá : Presentation at ASX Spotlight Investor Conference
PU
2017RESAPP HEALTHá : Provides SMARTCOUGH-C May Study Update
PU
2017RESAPP HEALTHá : ResAppDx to be Formally Evaluated by Médecins Sans Frontières/D..
PU
2017RESAPP HEALTHá : ResAppDx to be Formally Evaluated by Doctors Without Borders
PU
2017RESAPP HEALTHá : Extension of CEO and Managing Director's Contract
PU
2017RESAPP HEALTHá : Licenses Additional Pneumonia Diagnostic Tool from UniQuest
PU
2017RESAPP HEALTHá : Appendix 4C - Quarterly Mar 2017
PU
2017LNK : Change of Perth Address for Shareholder Purposes
PU
2017RESAPP HEALTHá : Extends SMARTCOUGH-C Study
PU
2017RESAPP HEALTHá : to Present at Upcoming Conferences in March
PU
2017RESAPP HEALTH (ASX : RAP) discusses revolutionary diagnostic app for respiratory..
FI
2017RESAPP HEALTHá : Appendix 3B
PU
2017RESAPP HEALTHá : Appendix 4C - Quarterly Dec 2016
PU
2017RESAPP HEALTHá : Announces Expanded Research Collaboration with MGH
PU
2017RESAPP HEALTHá : Announces Expanded Research Collaboration with Massachusetts Ge..
PU
2016RESAPP HEALTHá : Appendix 3B & Section 708A Notice
PU
2016RESAPP HEALTHá : Patersons Securities Initiates Research Coverage
PU
2016RESAPP HEALTHá : Receives Institutional Review Board Approval at Texas Children'..
PU
2016RESAPP HEALTHá : Receives Institutional Review Board Approval at Massachusetts G..
PU
2016RESAPP HEALTHá : Change of Director's Interest Notice x 4
PU
2016RESAPP HEALTHá : Appendix 3B
PU
2016RESAPP HEALTHá : Receives IRB Approval at Massachusetts General
PU
2016RESAPP HEALTHá : Confirmation of Change of Auditor
PU
2016RESAPP HEALTHá : Appendix 4C - Quarterly Sep 2016
PU
2016RESAPP HEALTHá : Appendix 3B & Section 708A Notice
PU
2016RESAPP HEALTHá : Receives First Institutional Review Board Approval for SMARTCOU..
PU
2016RESAPP HEALTHá : Receives First Institutional Review Board Approval
PU
2016RESAPP HEALTHá : Investor Presentation
PU
2016RESAPP HEALTHá : Appendix 3B & Section 708A Notice
PU
2016RESAPP HEALTHá : Announces Further Positive Results from Adult Clinical Study
PU
2016RESAPP HEALTHá : Further Positive Results From Adult Clinical Study
PU
2016RESAPP HEALTHá : Appendix 3B & Section 708A Notice
PU
2016RESAPP HEALTHá : Change in substantial holding
PU
1  2Next
Upcoming event on RESAPP HEALTH LIMITED